Meta-Analysis of Gadoxetic Acid Disodium (Gd-EOB-DTPA)-Enhanced Magnetic Resonance Imaging for the Detection of Liver Metastases

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Chen, Lihua ^a,b   Zhang, Jiuquan ^a   Zhang, Lin ^a   Bao, Jing ^c   Liu, Chen ^a   Xia, Yunbao ^b   Huang, Xuequan ^a   Wang, Jian ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b Taihu Hospital   (China)

^c NANTONG MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GADOXETIC ACID;

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ECHOGRAPHY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMAGE QUALITY; INTRAOPERATIVE PERIOD; LIVER METASTASIS; MAJOR CLINICAL STUDY; META ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

GADOLINIUM DTPA; HUMANS; LIVER; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84868703848     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048681     Document Type: Article

References (42)

1. Centeno BA, (2006) Pathology of liver metastases. Cancer Control 13: 13-26.
2. Kokudo N, Tada K, Seki M, Ohta H, Azekura K, et al. (2001) Anatomical major resection versus nonanatomical limited resection for liver metastases from colorectal carcinoma. Am J Surg 181: 153-159.
3. Qian J, (2011) Interventional therapies of unresectable liver metastases. J Cancer Res Clin Oncol 137: 1763-1772.
4. Motosugi U, Ichikawa T, Sou H, Sano K, Tominaga L, et al. (2010) Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging. Radiology 256: 151-158.
5. Hamm B, Staks T, Muhler A, Bollow M, Taupitz M, et al. (1995) Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 195: 785-792.
6. Reimer P, Rummeny EJ, Shamsi K, Balzer T, Daldrup HE, et al. (1996) Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. Radiology 199: 177-183.
7. Kim SH, Lee J, Kim MJ, Jeon YH, Park Y, et al. (2009) Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol 192: 1675-1681.
8. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J, (2003) The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 3: 25.
9. Whiting PF, Weswood ME, Rutjes AW, Reitsma JB, Bossuyt PN, et al. (2006) Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol 6: 9.
10. Higgins JP, Thompson SG, Deeks JJ, Altman DG, (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
11. Leeflang MM, Deeks JJ, Gatsonis C, Bossuyt PM, (2008) Systematic reviews of diagnostic test accuracy. Ann Intern Med 149: 889-897.
12. Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A (2006) Meta-DiSc: A software for meta-analysis of test accuracy data. BMC Medical Research Methodology 6.
13. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, et al. (2005) Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 58: 982-990.
14. Menke J (2010) Bivariate random-effects meta-analysis of sensitivity and specificity with SAS PROC GLIMMIX. Methods Inf Med 49: 54-62, 62-54.
15. Deeks JJ, Macaskill P, Irwig L, (2005) The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. Journal of Clinical Epidemiology 58: 882-893.
16. Schreiter NF, Nogami M, Steffen I, Pape UF, Hamm B, et al. (2012) Evaluation of the potential of PET-MRI fusion for detection of liver metastases in patients with neuroendocrine tumours. Eur Radiol 22: 458-467.
17. Goshima S, Kanematsu M, Watanabe H, Kondo H, Shiratori Y, et al. (2010) Hepatic hemangioma and metastasis: differentiation with gadoxetate disodium-enhanced 3-T MRI. AJR Am J Roentgenol 195: 941-946.
18. Kim YK, Lee YH, Kwak HS, Kim CS, Han YM, (2010) Detection of liver metastases: Gadoxetic acid-enhanced three-dimensional MR imaging versus ferucarbotran-enhanced MR imaging. Eur J Radiol 73: 131-136.
19. Lee MH, Kim SH, Kim H, Lee MW, Lee WJ, (2011) Differentiating focal eosinophilic infiltration from metastasis in the liver with gadoxetic Acid-enhanced magnetic resonance imaging. Korean J Radiol 12: 439-449.
20. Shimada K, Isoda H, Hirokawa Y, Arizono S, Shibata T, et al. (2010) Comparison of gadolinium-EOB-DTPA-enhanced and diffusion-weighted liver MRI for detection of small hepatic metastases. Eur Radiol 20: 2690-2698.
21. Kulemann V, Schima W, Tamandl D, Kaczirek K, Gruenberger T, et al. (2011) Preoperative detection of colorectal liver metastases in fatty liver: MDCT or MRI? Eur J Radiol 79: e1-e6.
22. Sofue K, Tsurusaki M, Tokue H, Arai Y, Sugimura K, (2011) Gd-EOB-DTPA-enhanced 3.0 T MR imaging: quantitative and qualitative comparison of hepatocyte-phase images obtained 10 min and 20 min after injection for the detection of liver metastases from colorectal carcinoma. Eur Radiol 21: 2336-2343.
23. Chung WS, Kim MJ, Chung YE, Kim YE, Park MS, et al. (2011) Comparison of gadoxetic acid-enhanced dynamic imaging and diffusion-weighted imaging for the preoperative evaluation of colorectal liver metastases. J Magn Reson Imaging 34: 345-353.
24. Muhi A, Ichikawa T, Motosugi U, Sou H, Nakajima H, et al. (2011) Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI. J Magn Reson Imaging 34: 326-335.
25. Motosugi U, Ichikawa T, Onohara K, Sou H, Sano K, et al. (2011) Distinguishing hepatic metastasis from hemangioma using gadoxetic acid-enhanced magnetic resonance imaging. Invest Radiol 46: 359-365.
26. Lowenthal D, Zeile M, Lim WY, Wybranski C, Fischbach F, et al. (2011) Detection and characterisation of focal liver lesions in colorectal carcinoma patients: comparison of diffusion-weighted and Gd-EOB-DTPA enhanced MR imaging. Eur Radiol 21: 832-840.
27. Motosugi U, Ichikawa T, Morisaka H, Sou H, Muhi A, et al. (2011) Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging: comparison with contrast-enhanced multi-detector row CT. Radiology 260: 446-453.
28. Bluemke DA, Sahani D, Amendola M, Balzer T, Breuer J, et al. (2005) Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study. Radiology 237: 89-98.
29. Donati OF, Hany TF, Reiner CS, von Schulthess GK, Marincek B, et al. (2010) Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI. J Nucl Med 51: 692-699.
30. Seo HJ, Kim MJ, Lee JD, Chung WS, Kim YE, (2011) Gadoxetate Disodium-Enhanced Magnetic Resonance Imaging Versus Contrast-Enhanced 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for the Detection of Colorectal Liver Metastases. Invest Radiol 46: 548-555.
31. Floriani I, Torri V, Rulli E, Garavaglia D, Compagnoni A, et al. (2010) Performance of imaging modalities in diagnosis of liver metastases from colorectal cancer: A systematic review and meta-analysis. Journal of Magnetic Resonance Imaging 31: 19-31.
32. Wiering B, Krabbe PFM, Jager GJ, Oyen WJG, Ruers TJM, (2005) The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases: A systematic review and metaanalysis. Cancer 104: 2658-2670.
33. Bipat S, van Leeuwen MS, Comans EF, Pijl ME, Bossuyt PM, et al. (2005) Colorectal liver metastases: CT, MR imaging, and PET for diagnosis-meta-analysis. Radiology 237: 123-131.
34. Niekel MC, Bipat S, Stoker J, (2010) Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiology 257: 674-684.
35. Wardlaw J, Chappell F, Best J, Wartolowska K, Berry E, (2006) Non-invasive imaging compared with intra-arterial angiography in the diagnosis of symptomatic carotid stenosis: a meta-analysis. Lancet 367: 1503-1512.
36. Kinkel K, Lu Y, Both M, Warren RS, Thoeni RF, (2002) Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology 224: 748-756.
37. Whiting P, Rutjes AW, Reitsma JB, Glas AS, Bossuyt PM, et al. (2004) Sources of variation and bias in studies of diagnostic accuracy: a systematic review. Ann Intern Med 140: 189-202.
38. Lijmer JG, Bossuyt PM, Heisterkamp SH, (2002) Exploring sources of heterogeneity in systematic reviews of diagnostic tests. Stat Med 21: 1525-1537.
39. McAuley L, Ba'Pham, Tugwell P, Moher D, (2000) Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses? Lancet 356: 1228-1231.
40. Ferda J, Mirka H, Kastner J, Ohlidalova K, Ferdova E, et al. (2008) Detection of the colorectal carcinoma liver metastases with magnetic resonance after intravenous application of hepatocellular contrast agent (Gd-EOB-DTPA), comparison with the intraoperative ultrasound. Ceska Radiologie 62: 60-65.
41. Davey J, Turner RM, Clarke MJ, Higgins JP, (2011) Characteristics of meta-analyses and their component studies in the Cochrane Database of Systematic Reviews: a cross-sectional, descriptive analysis. BMC Med Res Methodol 11: 160.
42. Gluud LL, Thorlund K, Gluud C, Woods L, Harris R, et al. (2008) Correction: reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med 149: 219.